Daiwa Securities Group Inc. Raises Position in DaVita Inc. (NYSE:DVA)

Daiwa Securities Group Inc. lifted its stake in DaVita Inc. (NYSE:DVA) by 9.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,839 shares of the company’s stock after purchasing an additional 507 shares during the period. Daiwa Securities Group Inc.’s holdings in DaVita were worth $809,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of DVA. Andra AP fonden increased its position in shares of DaVita by 9.0% in the 2nd quarter. Andra AP fonden now owns 192,300 shares of the company’s stock valued at $26,647,000 after purchasing an additional 15,800 shares during the last quarter. Prudential PLC lifted its position in shares of DaVita by 40.8% during the 2nd quarter. Prudential PLC now owns 15,980 shares of the company’s stock worth $2,214,000 after buying an additional 4,633 shares during the last quarter. Mount Lucas Management LP grew its position in shares of DaVita by 79.4% in the 2nd quarter. Mount Lucas Management LP now owns 34,133 shares of the company’s stock valued at $4,730,000 after buying an additional 15,104 shares during the last quarter. Koss Olinger Consulting LLC acquired a new stake in DaVita during the 2nd quarter worth $591,000. Finally, Caprock Group LLC purchased a new stake in DaVita in the second quarter valued at $276,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of DVA opened at $163.56 on Monday. The stock has a market capitalization of $13.72 billion, a P/E ratio of 18.59, a P/E/G ratio of 0.90 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. DaVita Inc. has a 1 year low of $71.51 and a 1 year high of $163.59. The company’s fifty day moving average is $145.17 and its two-hundred day moving average is $140.00.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.08 earnings per share. On average, sell-side analysts predict that DaVita Inc. will post 9.99 earnings per share for the current year.

Analysts Set New Price Targets

DVA has been the subject of a number of research analyst reports. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. TD Cowen increased their price objective on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Truist Financial lifted their target price on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a report on Tuesday, August 20th. UBS Group increased their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Bank of America raised their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $157.00.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the transaction, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at $12,137,038.31. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Michael David Staffieri sold 9,539 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total value of $1,431,136.17. Following the completion of the transaction, the chief operating officer now directly owns 241,945 shares of the company’s stock, valued at $36,299,008.35. The disclosure for this sale can be found here. In the last three months, insiders sold 113,601 shares of company stock valued at $17,525,449. Corporate insiders own 2.00% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.